chr6-89932398-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_021813.4(BACH2):c.*10T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000269 in 1,602,940 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.00052 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00024 ( 9 hom. )
Consequence
BACH2
NM_021813.4 3_prime_UTR
NM_021813.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.607
Genes affected
BACH2 (HGNC:14078): (BTB domain and CNC homolog 2) Enables sequence-specific double-stranded DNA binding activity. Involved in primary adaptive immune response involving T cells and B cells. Located in cytosol and nucleoplasm. Implicated in immunodeficiency 60. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 6-89932398-A-T is Benign according to our data. Variant chr6-89932398-A-T is described in ClinVar as [Benign]. Clinvar id is 3048364.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 79 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BACH2 | NM_021813.4 | c.*10T>A | 3_prime_UTR_variant | 9/9 | ENST00000257749.9 | ||
BACH2 | NM_001170794.2 | c.*10T>A | 3_prime_UTR_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BACH2 | ENST00000257749.9 | c.*10T>A | 3_prime_UTR_variant | 9/9 | 1 | NM_021813.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000519 AC: 79AN: 152158Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
79
AN:
152158
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000848 AC: 212AN: 250126Hom.: 4 AF XY: 0.000644 AC XY: 87AN XY: 135134
GnomAD3 exomes
AF:
AC:
212
AN:
250126
Hom.:
AF XY:
AC XY:
87
AN XY:
135134
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000243 AC: 352AN: 1450664Hom.: 9 Cov.: 30 AF XY: 0.000214 AC XY: 154AN XY: 719110
GnomAD4 exome
AF:
AC:
352
AN:
1450664
Hom.:
Cov.:
30
AF XY:
AC XY:
154
AN XY:
719110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000519 AC: 79AN: 152276Hom.: 1 Cov.: 31 AF XY: 0.000510 AC XY: 38AN XY: 74458
GnomAD4 genome
AF:
AC:
79
AN:
152276
Hom.:
Cov.:
31
AF XY:
AC XY:
38
AN XY:
74458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
27
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
BACH2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at